These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2632760)

  • 21. [Polymer-containing eye drops. I. Rheological characteristics of polymer solutions].
    Ugriné-Hunyadvári E; Kissné-Koczka C
    Acta Pharm Hung; 1995 Jan; 65(1):9-13. PubMed ID: 7725929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of the dropsize on the elimination of an ophthalmic solution from the precorneal area of human eyes.
    Ludwig A; Van Ooteghem M
    Pharm Acta Helv; 1987; 62(2):56-60. PubMed ID: 3575342
    [No Abstract]   [Full Text] [Related]  

  • 23. [Polymer-containing eye drops. II. Isotonicity and pH adjustment of polymer solutions].
    Ugriné-Hunyadvári E; Kissné Koczka C
    Acta Pharm Hung; 1995 Jan; 65(1):15-21. PubMed ID: 7725925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders.
    Stuart JC; Linn JG
    Ann Ophthalmol; 1985 Mar; 17(3):190-2. PubMed ID: 3873200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of bioadhesiveness of viscous solutions with naphazoline hydrochloride on the elimination of the drug from the eye of swine].
    Dittgen M; Oestereich S; Eckhardt D
    Pharmazie; 1991 Oct; 46(10):716-8. PubMed ID: 1803387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative rheological study on carbopol viscous solutions and, the evaluation of their suitability as the ophthalmic vehicles and artificial tears.
    Unlü N; Ludwig A; Van Ooteghem M; Hincal AA
    Pharm Acta Helv; 1992; 67(1):5-10. PubMed ID: 1561228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of selected polymers on the surface tension of solutions developed for the preparation of eye drops.
    Gasztych M; Burdzy K; Dołowacka-Jóźwiak A; Musiał W
    Polim Med; 2023; 53(2):111-116. PubMed ID: 38054367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for the obtaining of increased viscosity eye drops containing amikacin.
    Sikora A; Oszczapowicz I; Tejchman B; Grzechnik M
    Acta Pol Pharm; 2005; 62(1):31-7. PubMed ID: 16022491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VITRAX (sodium hyaluronate) in anterior segment surgery: a review and clinical study summary.
    Cobo M; Beaty N
    Adv Ther; 1990; 7(2):51-60. PubMed ID: 10149182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin.
    Bernatchez SF; Tabatabay C; Gurny R
    Graefes Arch Clin Exp Ophthalmol; 1993 Mar; 231(3):157-61. PubMed ID: 8462888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of solution viscosity on polymer precorneal residence time evaluated by in vitro method].
    Wei G; Ding PT; Cui YY; Li SM; Zheng JM
    Yao Xue Xue Bao; 2002 Jun; 37(6):469-72. PubMed ID: 12579809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T
    Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus.
    Dogru M; Kaderli B; Gelisken O; Yücel A; Avci R; Goto E; Shimmura S; Shimazaki J; Tsubota K
    Am J Ophthalmol; 2004 Sep; 138(3):381-8. PubMed ID: 15364219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of polysaccharide polymers in antihistamine eye drops: Influence on physicochemical properties and in vivo efficacy.
    Račić A; Jurišić Dukovski B; Lovrić J; Dobričić V; Vučen S; Micov A; Stepanović-Petrović R; Tomić M; Pecikoza U; Bajac J; Krajišnik D
    Int J Pharm; 2024 Apr; 655():124033. PubMed ID: 38522490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel plasminogen and hyaluronate sodium eye drop formulation for a patient with ligneous conjunctivitis.
    Conforti FM; Di Felice G; Bernaschi P; Bartuli A; Bianco G; Simonetti A; Buzzonetti L; Valente P; Corsetti T
    Am J Health Syst Pharm; 2016 Apr; 73(8):556-61. PubMed ID: 27045067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of biopharmaceutic characteristics of cromoglycate eye drops].
    Klimas R; Inkeniene AM; Briedis V; Gerbutaviciene RJ
    Medicina (Kaunas); 2003; 39 Suppl 2():96-103. PubMed ID: 14617868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of drug vehicle on ocular contact time of sulfacetamide sodium.
    Hanna C; Hof WC; Smith WG
    Ann Ophthalmol; 1985 Sep; 17(9):560-4. PubMed ID: 3904569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effect of viscous sodium hyaluronate solution on the rectal absorption of morphine.
    Matsumoto Y; Yamamoto I; Watanabe Y; Matsumoto M
    Biol Pharm Bull; 1995 Dec; 18(12):1744-9. PubMed ID: 8787799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of topically applied sodium cromoglycate in the albino rabbit eye.
    Lee VH; Swarbrick J; Stratford RE; Morimoto KW
    J Pharm Pharmacol; 1983 Jul; 35(7):445-50. PubMed ID: 6136586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of rheology in tears and artificial tears.
    A Arshinoff S; Hofmann I; Nae H
    J Cataract Refract Surg; 2021 May; 47(5):655-661. PubMed ID: 33278231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.